How to buy Precipio (PRPO) shares in Australia

Learn how to easily invest in Precipio shares.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Precipio Inc (PRPO) is a leading diagnostics & research business with stocks listed in the US. It opened the day at US$1.92 after a previous close of US$1.95. During the day the price has varied from a low of USD1.85 to a high of USD1.9374. The latest price was USD1.91 (25 minute delay). Precipio is listed on the NASDAQ. All prices are listed in US Dollars.

How to buy shares in Precipio

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Precipio. Find the share by name or ticker symbol: PRPO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Precipio reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$1.95, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Precipio, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Precipio. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Precipio stock price (NASDAQ:PRPO)

Use our graph to track the performance of PRPO stocks over time.

Precipio shares at a glance

Information last updated 2021-11-26.
OpenUS$1.92
HighUS$1.9374
LowUS$1.85
CloseUS$1.91
Previous closeUS$1.95
Change US$-0.04
Change % -2.0513%
Volume 125,766
Information last updated 2021-12-04.
52-week rangeUS$1.72 - US$5.75
50-day moving average US$2.3622
200-day moving average US$2.8972
Target priceUS$7
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) US$-0.357

Where to buy Precipio stock

Name Product Standard brokerage for US shares Currency conversion fee Markets
eToro (global stocks)
US$0
50 pips (US$0.50 for every AU$100 exchanged)
Global shares, US shares, ETFs
Zero brokerage share trading on US, Hong Kong and European stocks with trades as low as $50.
Note: This broker offers CFDs which are volatile investment products and most clients lose money trading CFDs with this provider.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
US$0
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Superhero share trading
US$0
50 pips (US$0.50 for every AU$100 exchanged)
ASX shares, US shares
Earn up to 15,000 Qantas frequent flyer points when you transfer an exisiting balance or trade. Offer valid for all new and existing Superhero members until 28 February.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
Saxo Capital Markets (Classic account)
US$4
1%
ASX shares, Global shares, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Invest
US$0
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
SelfWealth (Basic account)
US$9.5
0.60%
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Precipio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Precipio share growth calculator

US$

Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.

Considering buying Precipio shares?

Before you consider Precipio, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.

Show me how

Precipio price performance over time

Historical closes compared with the last close of $1.91

1 week (2021-11-29) -6.83%
1 month (2021-11-05) -18.38%
3 months (2021-09-03) -41.23%
6 months (2021-06-04) -44.48%
1 year (2020-12-04) -19.41%
2 years (2019-12-06) -5.91%
3 years (2018-12-06) -37.92%
5 years (2016-12-06) -39.45%

Precipio financials

Revenue TTM US$8.4 million
Gross profit TTM US$1.2 million
Return on assets TTM -21.41%
Return on equity TTM -41.15%
Profit margin -98.07%
Book value 1.14
Market capitalisation US$46.6 million

TTM: trailing 12 months

Precipio share dividends

We're not expecting Precipio to pay a dividend over the next 12 months.

Have Precipio's shares ever split?

Precipio's shares were split on a 1:15 basis on 28 April 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Precipio shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Precipio shares which in turn could have impacted Precipio's share price.

Precipio share price volatility

Over the last 12 months, Precipio's shares have ranged in value from as little as US$1.72 up to US$5.75. A popular way to gauge a stock's volatility is its "beta".

PRPO.US volatility(beta: 2.49)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precipio's is 2.4925. This would suggest that Precipio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Precipio overview

Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test; and ICE-COLD-PCR enables detection of abnormalities in blood samples. The company also operates a cancer diagnostic laboratory located in New Haven, Connecticut. It sells ICE-COLD-PCR technology kits to bio-pharma customers, clinical research, HemeScreen, and COVID-19 antibody tests. The company serves oncologists, hospitals, reference laboratories, physician-office labs, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania. The company is based in New Haven, Connecticut.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site